aspirin has been researched along with esculetin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Anderson, KM; DiGianfilippo, A; Harris, JE; Ondrey, FG; Wilson, DE | 1 |
| Altman, R; Scazziota, A | 1 |
| Mest, HJ; Riedel, A | 1 |
| Ip, MM; Koren, HS; Leung, KH | 1 |
| Adams, T; Manley, G; Steiner, S | 1 |
| Calzada, C; Ibrahim, S; Lagarde, M; Ponsin, G; Pruneta-Deloche, V | 1 |
1 review(s) available for aspirin and esculetin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
7 other study(ies) available for aspirin and esculetin
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Catechols; Cell Division; Cell Line; Cell Survival; DNA Replication; Glioma; Humans; Indomethacin; Kinetics; Lipoxygenase Inhibitors; Masoprocol; Pyrazoles; Rats; Tumor Cells, Cultured; Umbelliferones | 1989 |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenosine; Administration, Oral; Adult; Apyrase; Arachidonic Acids; Aspirin; Catechols; Drug Synergism; Epoprostenol; Humans; Indomethacin; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles; Thromboxane B2; Time Factors; Umbelliferones | 1986 |
The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Arrhythmias, Cardiac; Aspirin; Fibrinolytic Agents; Guinea Pigs; Lipoxygenase Inhibitors; Ouabain; Platelet Activating Factor; Sulfonamides; Umbelliferones | 1987 |
Regulation of human natural killing. IV. Role of lipoxygenase in regulation of natural killing activity.
Topics: Arachidonate 12-Lipoxygenase; Arachidonate Lipoxygenases; Aspirin; Cytotoxicity, Immunologic; Epoprostenol; Humans; Interferon Type I; Killer Cells, Natural; Lipoxygenase Inhibitors; Masoprocol; Phenanthrolines; Poly I-C; Umbelliferones | 1986 |
Effect of inhibitors of the lipoxygenase pathway on mouse myoblast fusion.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cell Fusion; Cells, Cultured; Cyclooxygenase Inhibitors; Indomethacin; Lipoxygenase Inhibitors; Mice; Muscles; Pyrazoles; Umbelliferones | 1984 |
The transfer of VLDL-associated phospholipids to activated platelets depends upon cytosolic phospholipase A2 activity.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Cytosol; Egtazic Acid; Estrenes; Humans; Lipoprotein Lipase; Lipoproteins, VLDL; Naphthalenes; Organophosphonates; Phospholipases A; Phospholipases A2; Phospholipid Transfer Proteins; Phospholipids; Platelet Activation; Pyrones; Pyrrolidinones; Thrombin; Umbelliferones | 2007 |